Kunming Longjin Pharmaceutical Co.,Ltd. Posted 9.4 Million Yuan Net Loss in First Quarter of 2023

Kunming Longjin Pharmaceutical Co.,Ltd. (昆明龙津药业股份有限公司) (002750.SZ) reported a net loss of 9.4 million yuan in the first quarter of 2023, reversing a net profit of 689,640 yuan for the same period in the previous year.

Meanwhile, the company posted 21.6 million yuan in revenue, down 54.7% year-on-year.

At the end of the reporting period, it had 685.9 million yuan in total assets and 90.5 million yuan in total liabilities, with a liability-to-asset ratio of 13.2%.